Journals / Selçuk Tıp Dergisi / 2020 / Cilt: 36 - Sayı: 1

The Clinical Features and Treatment Responses of Small Cell Lung Cancer Patients: A Single-Center Experience

Pages
27–32
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Definitions of survival were overall survival (TOS) and survival after metastasis (MOS).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Small cell lung cancer (SCLC) is associated with an aggressive course and short survival.
📊
Key Findings & Data:Results: The data of 161 patients were analyzed.
💡
Conclusion & Impact:Definitions of survival were overall survival (TOS) and survival after metastasis (MOS).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Small cell lung cancer (SCLC) is associated with an aggressive course and short survival. Conventional chemotherapy (CT) is the mainstay of SCLC treatment. In this study, we aimed to determine the current demographic and clinical characteristics of patients with SCLC and to determine their responses to the treatments. Patients and Methods: This was a retrospective, cross-sectional, cohort study. Definitions of survival were overall survival (TOS) and survival after metastasis (MOS). TOS was calculated as the time from the diagnosis to the date of death or last visit. MOS was calculated as the time from the diagnosis of metastasis to the date of death or last visit. Results: The data of 161 patients were analyzed. Response rates obtained with 1st line CT, 2nd line CT, and 3rd line CT were 72.2%, 43.3%, and 40.4%, respectively. The median TOS and median MOS were calculated as 15.7 months (0.03-106.97) and 13.79 months (0.03-79.54), respectively. The presence of metastatic disease at the time of diagnosis and refusal of treatment were statistically significant parameters affecting the median TOS. Conclusions: It was shown that the patients who received and were able to tolerate the treatment had obtained a survival advantage, regardless of the disease phase.

🔖

Cite This Article

KARAAGAC, M., YİLDİZ, O. (2020). The Clinical Features and Treatment Responses of Small Cell Lung Cancer Patients: A Single-Center Experience. Selçuk Tıp Dergisi, Cilt: 36 - Sayı: 1, 27–32. https://ajindex.com/articles/319000

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002;187:6-26
  2. Işıkoğlu M, Yalçın Ö, Günay S, et al. Türkiye’deki kadınlarda üriner ve anal inkontinansın prevalansı. 2000;1. İnternational Congress on the Menopause & The 4. National Congress, Antalya
  3. Ulmsten U, Henriksson L, Johnson P, et al. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:81-5
  4. Morey AF, Medendorp AR, Noller MW, et al. Transobturator versus transabdominal mid urethral slings: A multi-institutional comparison of obstructive voiding complications. J Urol 175 2006;1014-7
  5. Rardin CR, Rosenblatt N, Kohli JR. Release of tension-free vaginal tape for the treatment of refractory postoperative voiding dysfuction. Obstet Gyneacol 2002;100:898-902
  6. Khanuengkitkong S, Lo TS, Dass AK. Delayed vaginal and urethral mesh exposure: 10 years after TVT surgery. Int Urogynecol J 2013;24(3):519-21
  7. Boustead GB. The tension-free vaginal tape for treating female stress urinary incontinence. BJU Int 2002;89:687-93
  8. Özdemir A, Çakır S, Sözen H, et al. Development of bladder stone after tension free vaginal tape procedure: A case report. Journal of the Turkish German Gynecological Association 2011;12(4):256-8
  9. Blewniewski M, Markowski M, Kliś R, et al. Cystolithiasis in women as a distant complication after minimal invasive treatment of stress urinary incontinence. Central European Journal of Urology 2014;67(3):277-81
  10. Çoşkun B, Aksakal OS, Çoskun B, et al. The impact of concurrent pelvic organ prolapse reconstructive surgery on midurethral sling procedure outcome. Ginekol Pol 2018 89(4):189-94
  11. Naidu M, Thakar R, Sultan AH. Outcomes of minimally invasive suburethral slings with and without concomitant pelvic organ prolapse surgery. Int J Gynaecol Obstet 2014;127:(1):69-72.